Maravai Lifesciences Holdings (MRVI) Raw Materials (2020 - 2026)

Maravai Lifesciences Holdings' Raw Materials history runs 7 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• In Q1 2026, Raw Materials fell 25.32% year-over-year to $12.8 million; the TTM figure through Mar 2026 stood at $12.8 million (down 25.32% YoY), while the FY2025 annual figure was $14.6 million, down 13.95% from the prior year.
• Raw Materials was $12.8 million for Q1 2026 at Maravai Lifesciences Holdings, down from $14.6 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $26.8 million in Q3 2023 to a low of $12.8 million in Q1 2026.
• Historically, Raw Materials has averaged $18.3 million across 5 years, with a median of $17.2 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Raw Materials surged 43.39% in 2023, then slumped 37.79% in 2024.
• A 5-year view of Raw Materials shows it stood at $13.5 million in 2022, then jumped by 43.39% to $19.3 million in 2023, then declined by 12.22% to $17.0 million in 2024, then retreated by 13.95% to $14.6 million in 2025, then decreased by 12.02% to $12.8 million in 2026.
• The last three Raw Materials figures came in at $12.8 million (Q1 2026), $14.6 million (Q4 2025), and $16.0 million (Q3 2025), per Business Quant data.